Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Study Phase : Undisclosed
Sponsor : Astellas Gene Therapies
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : CYTOO pioneered MyoScreen™, an in vitro R&D platform that enables the evaluation of therapies in patient-derived primary skeletal muscle cells under physiological conditions.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 04, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Highest Development Status : Undisclosed
Sponsor : Astellas Gene Therapies
Deal Size : Inapplicable
Deal Type : Inapplicable